Cited 0 times in
Cross talk between P2 purinergic receptors modulates extracellular ATP-mediated interleukin-10 production in rat microglial cells.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seo, DR | - |
dc.contributor.author | Kim, SY | - |
dc.contributor.author | Kim, KY | - |
dc.contributor.author | Lee, HG | - |
dc.contributor.author | Moon, JH | - |
dc.contributor.author | Lee, JS | - |
dc.contributor.author | Lee, SH | - |
dc.contributor.author | Kim, SU | - |
dc.contributor.author | Lee, YB | - |
dc.date.accessioned | 2011-01-14T02:39:56Z | - |
dc.date.available | 2011-01-14T02:39:56Z | - |
dc.date.issued | 2008 | - |
dc.identifier.issn | 1226-3613 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/1144 | - |
dc.description.abstract | Previously we demonstrated that ATP released from LPS-activated microglia induced IL-10 expression in a process involving P2 receptors, in an autocrine fashion. Therefore, in the present study we sought to determine which subtype of P2 receptor was responsible for the modulation of IL-10 expression in ATP-stimulated microglia. We found that the patterns of IL-10 production were dose-dependent (1, 10, 100, 1,000 microM) and bell-shaped. The concentrations of ATP, ATP-gammaS, ADP, and ADP-betaS that showed maximal IL-10 release were 100, 10, 100, and 100 microM respectively. The rank order of agonist potency for IL-10 production was 2'-3'-O-(4-benzoyl)-benzoyl ATP (BzATP)=dATP>2-methylthio-ADP (2-meSADP). On the other hand, 2-methylthio-ATP (2-meSATP), alpha,beta-methylene ATP (alpha,beta-meATP), UTP, and UDP did not induce the release of IL-10 from microglia. Further, we obtained evidence of crosstalk between P2 receptors, in a situation where intracellular Ca(2+) release and/or cAMP-activated PKA were the main contributors to extracellular ATP-(or ADP)-mediated IL-10 expression, and IL-10 production was down-regulated by either MRS2179 (a P2Y(1) antagonist) or 5'-AMPS (a P2Y(11) antagonist), indicating that both the P2Y(1) and P2Y(11) receptors are major receptors involved in IL-10 expression. In addition, we found that inhibition of IL-10 production by high concentrations of ATP-gammaS (100 microM) was restored by TNP-ATP (an antagonist of the P2X(1), P2X(3), and P2X(4) receptors), and that IL-10 production by 2-meSADP was restored by 2meSAMP (a P2Y(12) receptor antagonist) or pertussis toxin (PTX; a Gi protein inhibitor), indicating that the P2X(1), P2X(3), P2X(4)receptor group, or the P2Y(12) receptor, negatively modulate the P2Y(11) receptor or the P2Y(1) receptor, respectively. | - |
dc.language.iso | en | - |
dc.subject.MESH | Adenosine Diphosphate | - |
dc.subject.MESH | Adenosine Triphosphate | - |
dc.subject.MESH | Adenylate Cyclase | - |
dc.subject.MESH | Animals | - |
dc.subject.MESH | Calcium | - |
dc.subject.MESH | Chelating Agents | - |
dc.subject.MESH | Cyclic AMP-Dependent Protein Kinases | - |
dc.subject.MESH | Enzyme Inhibitors | - |
dc.subject.MESH | Extracellular Space | - |
dc.subject.MESH | Gene Expression Regulation | - |
dc.subject.MESH | Interleukin-10 | - |
dc.subject.MESH | Microglia | - |
dc.subject.MESH | Purinergic P2 Receptor Agonists | - |
dc.subject.MESH | Purinergic P2 Receptor Antagonists | - |
dc.subject.MESH | RNA, Messenger | - |
dc.subject.MESH | Rats | - |
dc.subject.MESH | Rats, Sprague-Dawley | - |
dc.subject.MESH | Receptor Cross-Talk | - |
dc.subject.MESH | Receptors, Purinergic P2 | - |
dc.subject.MESH | Thionucleotides | - |
dc.title | Cross talk between P2 purinergic receptors modulates extracellular ATP-mediated interleukin-10 production in rat microglial cells. | - |
dc.type | Article | - |
dc.identifier.pmid | 18305394 | - |
dc.identifier.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2679320/ | - |
dc.contributor.affiliatedAuthor | 이, 용범 | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.3858/emm.2008.40.1.19 | - |
dc.citation.title | Experimental & molecular medicine | - |
dc.citation.volume | 40 | - |
dc.citation.number | 1 | - |
dc.citation.date | 2008 | - |
dc.citation.startPage | 19 | - |
dc.citation.endPage | 26 | - |
dc.identifier.bibliographicCitation | Experimental & molecular medicine, 40(1). : 19-26, 2008 | - |
dc.identifier.eissn | 2092-6413 | - |
dc.relation.journalid | J012263613 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.